These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 33473144
1. Protective role of estrogen against excessive erythrocytosis in Monge's disease. Azad P, Villafuerte FC, Bermudez D, Patel G, Haddad GG. Exp Mol Med; 2021 Jan; 53(1):125-135. PubMed ID: 33473144 [Abstract] [Full Text] [Related]
2. Senp1 drives hypoxia-induced polycythemia via GATA1 and Bcl-xL in subjects with Monge's disease. Azad P, Zhao HW, Cabrales PJ, Ronen R, Zhou D, Poulsen O, Appenzeller O, Hsiao YH, Bafna V, Haddad GG. J Exp Med; 2016 Nov 14; 213(12):2729-2744. PubMed ID: 27821551 [Abstract] [Full Text] [Related]
11. Hypoxia-inducible factor 1-mediated human GATA1 induction promotes erythroid differentiation under hypoxic conditions. Zhang FL, Shen GM, Liu XL, Wang F, Zhao YZ, Zhang JW. J Cell Mol Med; 2012 Aug 01; 16(8):1889-99. PubMed ID: 22050843 [Abstract] [Full Text] [Related]
12. High serum testosterone levels are associated with excessive erythrocytosis of chronic mountain sickness in men. Gonzales GF, Gasco M, Tapia V, Gonzales-Castañeda C. Am J Physiol Endocrinol Metab; 2009 Jun 01; 296(6):E1319-25. PubMed ID: 19318512 [Abstract] [Full Text] [Related]
13. Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease). Sharma S, Gralla J, Ordonez JG, Hurtado ME, Swenson ER, Schoene RB, Kelly JP, Callacondo D, Rivard C, Roncal-Jimenez C, Sirota J, Fuquay R, Jackson BP, Swenson KE, Johnson RJ, Hurtado A, Escudero E. Respir Physiol Neurobiol; 2017 Dec 01; 246():1-8. PubMed ID: 28720395 [Abstract] [Full Text] [Related]